The Food and Drug Administration (FDA) has approved 4 updated 2026–2027 COVID-19 vaccines for the upcoming respiratory virus season. All of the new formulations have been updated for XFG variant, according to FDA, and all follow the somewhat tighter age and risk restrictions that were introduced in 2025. Prior to the 2024–2025 season, vaccination was broadly recommended for everyone aged 6 months and older. Now, a healthy 50-year-old with no underlying risk factor, for example, …
Read More









